Caitong International Asset Management Co., LTD Centessa Pharmaceuticals PLC Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 21 shares of CNTA stock, worth $358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 21
-0.0%
Holding current value
$358
Previous $352,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
117Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$341 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$170 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$165 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$108 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$99.1 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.61B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...